FDA Grants Approval for Hypogonadism Treatment

THURSDAY, March 28, 2019 -- Jatenzo (testosterone undecanoate), an oral testosterone capsule, has been approved to treat men with certain forms of hypogonadism, the U.S. Food and Drug Administration announced Wednesday. The capsule is indicated for...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news